PATENT CLAIM ANALYSIS

Application Number: 15889494
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["514", "171000"]

Abstract:
The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.

Claim (Index 24):
The method of  claim 16 , wherein the cancer is selected from the group consisting of leukemia, lymphoma, neuroblastoma, and bone cancer, breast cancer, prostate cancer, ovary cancer, skin cancer, brain cancer, bladder cancer, cervical cancer, liver cancer, and lung cancer.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 88.0
- Lexical Diversity: 1.05263
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15621013', '15013218', '14487347', '13901946', '14549885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8969578353585977
- 35 USC 102 Novelty (BERT): 0.5633261409886824
- Combined Prediction Score: 0.8635946659216063
- Mean Citation Score: 617.3997919999998
- Max Citation Score: 630.0679
- Similarity Product: 326.91461604355567

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test